DarioHealth Corp.
DRIO
$0.666
-$0.0315-4.52%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 17.26% | 110.29% | 111.00% | 1.67% | -18.50% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.26% | 110.29% | 111.00% | 1.67% | -18.50% |
| Cost of Revenue | -7.77% | -11.14% | 22.20% | -24.06% | -23.22% |
| Gross Profit | 32.32% | 343.82% | 204.25% | 25.92% | -15.37% |
| SG&A Expenses | -32.70% | -1.63% | -0.29% | 11.64% | 31.06% |
| Depreciation & Amortization | -24.76% | 16.56% | 21.52% | 12.71% | 7.59% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -31.56% | 4.74% | 2.04% | 11.27% | 21.25% |
| Operating Income | 47.30% | 22.35% | 22.62% | -15.49% | -43.89% |
| Income Before Tax | -0.39% | 33.36% | 21.54% | 17.94% | 28.51% |
| Income Tax Expenses | 101.10% | 142.19% | -- | -- | -- |
| Earnings from Continuing Operations | -28.60% | 32.57% | 21.62% | 17.94% | 44.05% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -28.60% | 32.57% | 21.62% | 17.94% | 44.05% |
| EBIT | 47.30% | 22.35% | 22.62% | -15.49% | -43.89% |
| EBITDA | 50.67% | 34.35% | 27.85% | -12.12% | -47.59% |
| EPS Basic | 28.59% | 70.11% | 50.20% | 85.41% | 55.46% |
| Normalized Basic EPS | 26.98% | 77.26% | 44.05% | 41.92% | 42.84% |
| EPS Diluted | 28.59% | 70.11% | 49.25% | 85.41% | 55.46% |
| Normalized Diluted EPS | 26.98% | 77.26% | 44.05% | 41.92% | 42.84% |
| Average Basic Shares Outstanding | 37.53% | 172.91% | 40.26% | 41.31% | 24.93% |
| Average Diluted Shares Outstanding | 37.53% | 172.91% | 40.26% | 41.31% | 24.93% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |